Linezolid in the treatment of Gram-positive prosthetic joint infections (Q34393206)

From Wikidata

Revision as of 10:38, 25 December 2022 by Charles Matthews (talk | contribs) (‎Updated Item: Changing author name 'Matteo Bassetti' to P50:Matteo Bassetti (Q88607142) (via author_strings gadget))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Linezolid in the treatment of Gram-positive prosthetic joint infections	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Linezolid in the treatment of Gram-positive prosthetic joint infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

gram-positive bacteria

0 references

1 reference

based on heuristic

inferred from title

Matteo Bassetti

1

object named as

Matteo Bassetti

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Francesco Vitale

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Giovanna Melica

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Elda Righi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Antonio Di Biagio

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Luigi Molfetta

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francesco Pipino

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mario Cruciani

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dante Bassetti

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

10 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

387-390

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Linezolid penetration into osteo-articular tissues

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Linezolid treatment of total prosthetic knee infection due to methicillin-resistant Staphylococcus epidermidis.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Antibiotic treatment of gram-positive bone and joint infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Hematologic effects of linezolid: summary of clinical experience

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Linezolid-associated toxic optic neuropathy: a report of 2 cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI016

21 January 2018

Identifiers

10.1093/JAC/DKI016

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34393206&oldid=1795568007"